Virax Biolabs
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Virax Biolabs and other ETFs, options, and stocks.About VRAX
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
CEOJames Foster
CEOJames Foster
Employees19
Employees19
HeadquartersLanarkshire, Scotland
HeadquartersLanarkshire, Scotland
Founded2013
Founded2013
Employees19
Employees19
VRAX Key Statistics
Market cap2.09M
Market cap2.09M
Price-Earnings ratio-0.37
Price-Earnings ratio-0.37
Dividend yield—
Dividend yield—
Average volume30.61M
Average volume30.61M
High today$0.50
High today$0.50
Low today$0.46
Low today$0.46
Open price$0.50
Open price$0.50
Volume529.68K
Volume529.68K
52 Week high$3.20
52 Week high$3.20
52 Week low$0.35
52 Week low$0.35
Stock Snapshot
Virax Biolabs(VRAX) stock is priced at $0.47, giving the company a market capitalization of 2.09M. It carries a P/E multiple of -0.37.
As of 2025-12-10, Virax Biolabs(VRAX) stock has fluctuated between $0.46 and $0.50. The current price stands at $0.47, placing the stock +2.3% above today's low and -5.9% off the high.
Virax Biolabs(VRAX) shares are trading with a volume of 529.68K, against a daily average of 30.61M.
During the past year, Virax Biolabs(VRAX) stock moved between $0.35 at its lowest and $3.20 at its peak.
During the past year, Virax Biolabs(VRAX) stock moved between $0.35 at its lowest and $3.20 at its peak.
People also own
Based on the portfolios of people who own VRAX. This list is generated using Robinhood data, and it’s not a recommendation.